Mutation Subtypes | List of Frontiers open access articles

Original Research

Published on 18 Aug 2022

Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma

in Cancer Imaging and Image-directed Interventions

Ji-wen Huo
Tian-you Luo
Le Diao
Fa-jin Lv
Wei-dao Chen
Rui-ze Yu
Qi Li

Frontiers in Oncology

doi 10.3389/fonc.2022.846589

3,430 views
6 citations

Review

Published on 21 Oct 2022

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

in Cancer Genetics and Oncogenomics

Liyuan Gao
Weizhang Shen

Frontiers in Genetics

doi 10.3389/fgene.2022.890247

11,933 views
11 citations

Original Research

Published on 12 Oct 2023

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study

in Molecular and Cellular Oncology

Ruihua Zhao
Tianqi An
Min Liu
Yanan Zhou
Rui Li
Guozhong Jiang
Jing Li
Xinguang Cao
Hong Zong

Frontiers in Oncology

doi 10.3389/fonc.2023.1272046

5,063 views
2 citations

Original Research

Published on 15 Nov 2024

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

in Thoracic Oncology

Peng Hao
Yinghong Yu
Chan-Tao Huang
Fang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1464555

2,473 views
1 citation

Systematic Review

Published on 06 Nov 2025

Association between point mutations of macrolide-resistant Mycoplasma pneumoniae and clinical antibiotic treatment efficacy: a meta-analysis

in Pharmacology of Infectious Diseases

Rutong Wang
Junfeng He
Yingqi Feng
Mengyao Wang
Chi Zhong
Siqin He
Siqi Tu
Na Wen
Chuan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1682167

1,471 views

Original Research

Published on 21 Feb 2022

Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers

in Cancer Immunity and Immunotherapy

Youming Lei
Kun Wang
Yinqiang Liu
Xuming Wang
Xudong Xiang
Xiangu Ning
Wanbao Ding
Jin Duan
Dingbiao Li
Wei Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2022.811601

9,487 views
17 citations

Original Research

Published on 04 Sep 2019

Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay

in Women's Cancer

Shuangni Yu
Huilin Shao
Xinchao Ban
Hongkai Zhang
Yan You
Na Zhou
Xinxin Mao
He Zhao
Jie Chen
Zhaohui Lu

Frontiers in Oncology

doi 10.3389/fonc.2019.00831

12,537 views
24 citations

Original Research

Published on 24 Oct 2023

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Qi Wang
Zhuoran Tang
Chunyu Li
Xuefei Li
Chunxia Su

Frontiers in Immunology

doi 10.3389/fimmu.2023.1297588

4,922 views
10 citations

Review

Published on 05 Jan 2022

Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Mo Shen
Rongbin Qi
Justin Ren
Dongqing Lv
Haihua Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.780655

16,043 views
31 citations

Original Research

Published on 24 Oct 2019

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations

in Hematologic Malignancies

Li Yang
Ke'Feng Shen
Mei'Lan Zhang
Wei Zhang
Hao'Dong Cai
Li'Man Lin
Xiao'Lu Long
Shu'Gang Xing
Yang Tang
Jie Xiong

Frontiers in Oncology

doi 10.3389/fonc.2019.01133

5,060 views
8 citations

Original Research

Published on 03 Sep 2025

Enhanced prediction of gene mutation and risk stratification in non-small-cell lung cancer through dual-pathway fusion of radiomics and pathomics

in Thoracic Oncology

Yang Ji
Ruisheng Ge
Wei Meng
Xinxin Yang
Hongguang Lu
Bei Lu
Chenglong Zheng
Yang Teng
Hong Pan
Ling Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1646851

2,385 views

Original Research

Published on 11 Mar 2022

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients

in Molecular Recognition

Shuhang Wang
Qin Li
Peiwen Ma
Yuan Fang
Yue Yu
Ning Jiang
Huilei Miao
Qiyu Tang
Yuqi Yang
Shujun Xing

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2022.831382

10,436 views
14 citations

Systematic Review

Published on 23 Jan 2024

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

in Thoracic Oncology

Rodrigo Motta-Guerrero
Alejandro Leon Garrido-Lecca
Virgilio E. Failoc-Rojas
Ana Calle-Villavicencio
Robert Villacorta-Carranza
Yesenia Huerta-Collado
Alicia Torres-Mera
Mario J. Valladares-Garrido
Víctor Rivera-Francia
Carlos Carracedo

Frontiers in Oncology

doi 10.3389/fonc.2023.1335373

4,277 views
4 citations

Review

Published on 06 Feb 2026

The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications

in Cancer Immunity and Immunotherapy

Luo Liang
Weidong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1753215

1,267 views

Original Research

Published on 21 Nov 2022

Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data

in Cancer Genetics and Oncogenomics

Miao Jiang
Yongliang Jia
Jinming Han
Jianxiang Shi
Chang Su
Rui Zhang
Menglu Xing
Shuiling Jin
Hong Zong

Frontiers in Genetics

doi 10.3389/fgene.2022.963964

6,457 views
9 citations

Original Research

Published on 13 Dec 2022

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Manxiong Dai
Raja Jahanzaib
Yan Liao
Fengxuan Yao
Jia Li
Xiong Teng
Kang Chen
Wei Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.1074538

4,944 views
13 citations

Articles

Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

Association between point mutations of macrolide-resistant Mycoplasma pneumoniae and clinical antibiotic treatment efficacy: a meta-analysis

Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers

Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma

Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations

Enhanced prediction of gene mutation and risk stratification in non-small-cell lung cancer through dual-pathway fusion of radiomics and pathomics

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications

Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection